Skip to main content
Erschienen in: Acta Neurologica Belgica 4/2019

08.04.2019 | Original Article

Early predictors of functional disability in Guillain–Barré Syndrome

verfasst von: Abdulkadir Tunç

Erschienen in: Acta Neurologica Belgica | Ausgabe 4/2019

Einloggen, um Zugang zu erhalten

Abstract

This study investigated the predictors of prognosis at admission and after the first month in Guillain–Barré syndrome (GBS) patients. This retrospective study used the electronic records of 81 GBS patients. Age, gender, previous GBS history, antecedent febrile illness and presence of cranial nerve dysfunction were recorded. Detailed neurological examinations, routine biochemical and haematological investigations, cerebrospinal fluid (CSF) analysis and electrophysiological studies, GBS subtypes and treatments were assessed. Hughes disability scores (HDSs) were evaluated at the end of the first day and first month. The GBS patient group included 44 male (54.3%) and 37 female (45.7%) patients. The mean age was 52.2 ± 18.5. The mean HDS score was 2.96 at admission and 1.94 at the end of the first month. Plasma sodium, albumin, and CSF protein levels were significantly correlated with low admission HDS scores (p = 0.03, p  = 0.011, p  = 0.036, and p  < 0.001, respectively). Age, plasma sodium, albumin, neutrophil, neutrophil/lymphocyte ratio (NLR) levels, C-reactive protein (CRP) and CSF protein levels were significantly correlated with poor prognosis at the end of the first month (p < 0.05). Concomitant cranial nerve palsies were significantly correlated with low HDS scores (p = 0.011, p = 0.02) but antecedent events were not correlated with functional disability (p = 0.686, p = 0.413). Decreased albumin and sodium levels and increased CSF protein levels indicated poor GBS prognosis. Higher age, elevated NLR, and higher CRP levels indicated worse prognosis at the end of the first month. However, further studies are needed.
Literatur
1.
Zurück zum Zitat Van den Berg B, Walgaard C, Drenthen J et al (2014) Guillain–Barré syndrome: pathogenesis, diagnosis, treatment and prognosis. Nat Rev Neurol 10(8):469–482CrossRef Van den Berg B, Walgaard C, Drenthen J et al (2014) Guillain–Barré syndrome: pathogenesis, diagnosis, treatment and prognosis. Nat Rev Neurol 10(8):469–482CrossRef
2.
Zurück zum Zitat Ozdemir HH (2016) Analysis of the albumin level, neutrophil-lymphocyte ratio, and platelet-lymphocyte ratio in Guillain–Barré syndrome. Arq Neuropsiquiatr 74(9):718–722CrossRef Ozdemir HH (2016) Analysis of the albumin level, neutrophil-lymphocyte ratio, and platelet-lymphocyte ratio in Guillain–Barré syndrome. Arq Neuropsiquiatr 74(9):718–722CrossRef
3.
Zurück zum Zitat Sahin S, Cinar N, Karsidag S (2017) Are cerebrospinal fluid protein levels and plasma neutrophil/lymphocyte ratio associated with prognosis of Guillain Barré syndrome? Neurol Int 9(2):7032CrossRef Sahin S, Cinar N, Karsidag S (2017) Are cerebrospinal fluid protein levels and plasma neutrophil/lymphocyte ratio associated with prognosis of Guillain Barré syndrome? Neurol Int 9(2):7032CrossRef
4.
Zurück zum Zitat DiCapua DB, Lakraj AA, Nowak RJ et al (2015) Relationship between cerebrospinal fluid protein levels and electrophysiologic abnormalities in Guillain–Barré syndrome. J Clin Neuromuscul Dis 17(2):47–51CrossRef DiCapua DB, Lakraj AA, Nowak RJ et al (2015) Relationship between cerebrospinal fluid protein levels and electrophysiologic abnormalities in Guillain–Barré syndrome. J Clin Neuromuscul Dis 17(2):47–51CrossRef
5.
Zurück zum Zitat Fokke C, van den Berg B, Drenthen J et al (2014) Diagnosis of Guillain–Barr´e syndrome and validation of Brighton criteria. Brain 137:33–43CrossRef Fokke C, van den Berg B, Drenthen J et al (2014) Diagnosis of Guillain–Barr´e syndrome and validation of Brighton criteria. Brain 137:33–43CrossRef
6.
Zurück zum Zitat Yuki N, Hartung HP (2012) Guillain–Barr´e syndrome. N Engl J Med 366:2294–2304CrossRef Yuki N, Hartung HP (2012) Guillain–Barr´e syndrome. N Engl J Med 366:2294–2304CrossRef
7.
Zurück zum Zitat Rajabally YA, Uncini A (2012) Outcome and its predictors in Guillain–Barre syndrome. J Neurol Neurosurg Psychiatry 83(7):711–718CrossRef Rajabally YA, Uncini A (2012) Outcome and its predictors in Guillain–Barre syndrome. J Neurol Neurosurg Psychiatry 83(7):711–718CrossRef
8.
Zurück zum Zitat Walgaard C, Lingsma HF, Ruts L et al (2011) Early recognition of poor prognosis in Guillain–Barre syndrome. Neurology 76:968–975CrossRef Walgaard C, Lingsma HF, Ruts L et al (2011) Early recognition of poor prognosis in Guillain–Barre syndrome. Neurology 76:968–975CrossRef
9.
Zurück zum Zitat Verma R, Chaudhari TS, Raut TP et al (2013) Clinico-electrophysiological profile and predictors of functional outcome in Guillain–Barre syndrome (GBS). J Neurol Sci 335(1–2):105–111CrossRef Verma R, Chaudhari TS, Raut TP et al (2013) Clinico-electrophysiological profile and predictors of functional outcome in Guillain–Barre syndrome (GBS). J Neurol Sci 335(1–2):105–111CrossRef
10.
Zurück zum Zitat Vaishnavi C, Kapoor P, Behura C et al (2014) C-reactive protein in patients with Guillain Barré syndrome. Indian J Pathol Microbiol 57(1):51–54CrossRef Vaishnavi C, Kapoor P, Behura C et al (2014) C-reactive protein in patients with Guillain Barré syndrome. Indian J Pathol Microbiol 57(1):51–54CrossRef
11.
Zurück zum Zitat Sipilä JO, Kauko T, Soilu-Hänninen M (2017) Admission sodium level and prognosis in adult Guillain–Barré syndrome. Int J Neurosci 127(4):344–349CrossRef Sipilä JO, Kauko T, Soilu-Hänninen M (2017) Admission sodium level and prognosis in adult Guillain–Barré syndrome. Int J Neurosci 127(4):344–349CrossRef
12.
Zurück zum Zitat Huang Y, Ying Z, Chen Z et al (2017) Thyroid hormone level is associated with the frequency and severity of Guillain–Barré syndrome. Int J Neurosci 127(10):893–899CrossRef Huang Y, Ying Z, Chen Z et al (2017) Thyroid hormone level is associated with the frequency and severity of Guillain–Barré syndrome. Int J Neurosci 127(10):893–899CrossRef
13.
Zurück zum Zitat Asbury AK, Cornblath DR (1990) Assessment of current diagnostic criteria for Guillain–Barré syndrome. Ann Neurol 27:21–24CrossRef Asbury AK, Cornblath DR (1990) Assessment of current diagnostic criteria for Guillain–Barré syndrome. Ann Neurol 27:21–24CrossRef
14.
Zurück zum Zitat Hughes RA, Newsom-Davis JM, Perkin GD et al (1978) Controlled trial prednisolone in acute polyneuropathy. Lancet 2(8093):750–753CrossRef Hughes RA, Newsom-Davis JM, Perkin GD et al (1978) Controlled trial prednisolone in acute polyneuropathy. Lancet 2(8093):750–753CrossRef
15.
Zurück zum Zitat Hadden RD, Cornblath DR, Hughes RA et al (1998) Electrophysiological classification of Guillain–Barré syndrome: clinical associations and outcome. Plasma exchange/sandoglobulin Guillain–Barré syndrome trial group. Ann Neurol 44(5): 780–788CrossRef Hadden RD, Cornblath DR, Hughes RA et al (1998) Electrophysiological classification of Guillain–Barré syndrome: clinical associations and outcome. Plasma exchange/sandoglobulin Guillain–Barré syndrome trial group. Ann Neurol 44(5): 780–788CrossRef
16.
Zurück zum Zitat Goverman J (2009) Autoimmune T cell responses in the central nervous system. Nat Rev Immunol 9:393–407CrossRef Goverman J (2009) Autoimmune T cell responses in the central nervous system. Nat Rev Immunol 9:393–407CrossRef
17.
Zurück zum Zitat Gonzalez-Quevedo A, Carriera RF, O’Farrill ZL et al (2009) An appraisal of blood-cerebrospinal fluid barrier dysfunction during the course of Guillain–Barré syndrome. Neurol India 57:288–294CrossRef Gonzalez-Quevedo A, Carriera RF, O’Farrill ZL et al (2009) An appraisal of blood-cerebrospinal fluid barrier dysfunction during the course of Guillain–Barré syndrome. Neurol India 57:288–294CrossRef
18.
Zurück zum Zitat Brettschneider J, Petzold A, Süssmuth S et al (2009) Cerebrospinal fluid biomarkers in Guillain–Barré syndrome—where do we stand? J Neurol 256:3–12CrossRef Brettschneider J, Petzold A, Süssmuth S et al (2009) Cerebrospinal fluid biomarkers in Guillain–Barré syndrome—where do we stand? J Neurol 256:3–12CrossRef
19.
Zurück zum Zitat Kerasnoudis A, Pitarokoili K, Behrendt V et al (2014) Increased cerebrospinal fluid protein and motor conduction studies as prognostic markers of outcome and nerve ultrasound changes in Guillain–Barré syndrome. J Neurol Sci 340(1–2):37–43CrossRef Kerasnoudis A, Pitarokoili K, Behrendt V et al (2014) Increased cerebrospinal fluid protein and motor conduction studies as prognostic markers of outcome and nerve ultrasound changes in Guillain–Barré syndrome. J Neurol Sci 340(1–2):37–43CrossRef
20.
Zurück zum Zitat Ghabaee M, Jabedari B, Al-E-Eshagh N et al (2010) Serum and cerebrospinal fluid antioxidant activity and lipid peroxidation in Guillain–Barre syndrome and multiple sclerosis patients. Int J Neurosci 120:301–304CrossRef Ghabaee M, Jabedari B, Al-E-Eshagh N et al (2010) Serum and cerebrospinal fluid antioxidant activity and lipid peroxidation in Guillain–Barre syndrome and multiple sclerosis patients. Int J Neurosci 120:301–304CrossRef
21.
Zurück zum Zitat Gilgun-Sherki Y, Melamed E, Offen D (2004) The role of oxidative stress in the pathogenesis of multiple sclerosis: the need for effective antioxidant therapy. J Neurol 251:261–268CrossRef Gilgun-Sherki Y, Melamed E, Offen D (2004) The role of oxidative stress in the pathogenesis of multiple sclerosis: the need for effective antioxidant therapy. J Neurol 251:261–268CrossRef
22.
Zurück zum Zitat Di Giuseppe D, Ulivelli M, Bartalini S et al (2010) Regulation of redox forms of plasma thiols by albumin in multiple sclerosis after fasting and methionine loading test. Amino Acids 38:1461–1471CrossRef Di Giuseppe D, Ulivelli M, Bartalini S et al (2010) Regulation of redox forms of plasma thiols by albumin in multiple sclerosis after fasting and methionine loading test. Amino Acids 38:1461–1471CrossRef
23.
Zurück zum Zitat Su Z, Chen Z, Xiang Y et al (2017) Low serum levels of uric acid and albumin in patients with Guillain–Barre syndrome. Medicine (Baltimore) 96(15):e6618CrossRef Su Z, Chen Z, Xiang Y et al (2017) Low serum levels of uric acid and albumin in patients with Guillain–Barre syndrome. Medicine (Baltimore) 96(15):e6618CrossRef
24.
Zurück zum Zitat Saifudheen K, Jose J, Gafoor VA et al (2011) Guillain–Barr´ e syndrome and SIADH. Neurology 76:701–704CrossRef Saifudheen K, Jose J, Gafoor VA et al (2011) Guillain–Barr´ e syndrome and SIADH. Neurology 76:701–704CrossRef
25.
Zurück zum Zitat Wang Y, Liu J (2015) Hyponatremia is a predictor for poor outcome in Guillain–Barr´e syndrome. Neurol Res 37:347–351CrossRef Wang Y, Liu J (2015) Hyponatremia is a predictor for poor outcome in Guillain–Barr´e syndrome. Neurol Res 37:347–351CrossRef
26.
Zurück zum Zitat Hiew FL, Winer JB, Rajabally YA (2016) Hyponatraemia in Guillain–Barre’ syndrome revisited. Acta Neurol Scand 133:295–301CrossRef Hiew FL, Winer JB, Rajabally YA (2016) Hyponatraemia in Guillain–Barre’ syndrome revisited. Acta Neurol Scand 133:295–301CrossRef
27.
Zurück zum Zitat van Koningsveld R, van Doorn PA, Schmitz PI et al (2000) Mild forms of Guillain–Barré syndrome in an epidemiologic survey in The Netherlands. Neurology 54:620–625CrossRef van Koningsveld R, van Doorn PA, Schmitz PI et al (2000) Mild forms of Guillain–Barré syndrome in an epidemiologic survey in The Netherlands. Neurology 54:620–625CrossRef
28.
Zurück zum Zitat Walgaard C, Lingsma HF, Ruts L et al (2011) Early recognition of poor prognosis in Guillain–Barre ´ syndrome. Neurology 76: 968e75CrossRef Walgaard C, Lingsma HF, Ruts L et al (2011) Early recognition of poor prognosis in Guillain–Barre ´ syndrome. Neurology 76: 968e75CrossRef
29.
Zurück zum Zitat Seta T, Nagayama H, Katsura K et al (2005) Factors influencing outcome in Guillain–Barré Syndrome: comparison of plasma adsorption against other treatments. Clin Neurol Neurosurg 107(6):491–496CrossRef Seta T, Nagayama H, Katsura K et al (2005) Factors influencing outcome in Guillain–Barré Syndrome: comparison of plasma adsorption against other treatments. Clin Neurol Neurosurg 107(6):491–496CrossRef
30.
Zurück zum Zitat Alan S, Tuna S, Türkoğlu EB (2015) The relation of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and mean platelet volume with the presence and severity of Behçet’s syndrome. Kaohsiung J Med Sci 31(12):626–631CrossRef Alan S, Tuna S, Türkoğlu EB (2015) The relation of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and mean platelet volume with the presence and severity of Behçet’s syndrome. Kaohsiung J Med Sci 31(12):626–631CrossRef
31.
Zurück zum Zitat Berciano J, Figols J, García A et al (1997) Fulminant Guillain–Barré syndrome with universal inexcitability of peripheral nerves: a clinicopathological study. Muscle Nerve 20(7):846–857CrossRef Berciano J, Figols J, García A et al (1997) Fulminant Guillain–Barré syndrome with universal inexcitability of peripheral nerves: a clinicopathological study. Muscle Nerve 20(7):846–857CrossRef
32.
Zurück zum Zitat Lobo SM (2012) Sequential C-reactive protein measurements in patients with serious infections: does it help? Crit Care 16:130CrossRef Lobo SM (2012) Sequential C-reactive protein measurements in patients with serious infections: does it help? Crit Care 16:130CrossRef
Metadaten
Titel
Early predictors of functional disability in Guillain–Barré Syndrome
verfasst von
Abdulkadir Tunç
Publikationsdatum
08.04.2019
Verlag
Springer International Publishing
Erschienen in
Acta Neurologica Belgica / Ausgabe 4/2019
Print ISSN: 0300-9009
Elektronische ISSN: 2240-2993
DOI
https://doi.org/10.1007/s13760-019-01133-3

Weitere Artikel der Ausgabe 4/2019

Acta Neurologica Belgica 4/2019 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.